Your Guide to Personalised Healthcare

Learn from the AttoDiagnostics blog.

Unlocking the Power of PGx in Statin Therapy

Published 21/11/2024

Statins are the most frequently prescribed medications for reducing LDL cholesterol and managing cardiovascular conditions. They play a crucial role in preventing heart attacks and strokes. Despite their widespread use and proven efficacy, not all patients respond favourably to statins; some fail to achieve effective cholesterol reduction, while others experience adverse effects. For instance, both Lovastatin and Simvastatin have been associated with an increased risk of muscle and liver toxicity.

The Economic Benefits of Pharmacogenomics (PGx) Testing: Predicting Cost Savings in Healthcare

Published 13/11/2024

In the era of personalised medicine, pharmacogenomics (PGx) testing is gaining traction as a powerful tool for tailoring drug therapies to individual genetic profiles. While the primary focus of PGx testing is to improve patient outcomes by optimising drug efficacy and minimising adverse drug reactions (ADRs), there is growing evidence that it can also lead to significant cost savings in healthcare. This blog explores the economic benefits of PGx testing, drawing on several key studies that predict substantial savings through its implementation

Pharmacogenomic Testing (PGx) to Support Contraceptives

Published 04/11/2024

Finding the right contraceptive for an individual has always proven to be a difficult task as each person responds differently. Each person has a unique genetic makeup that affects how they metabolise or respond to various hormonal contraceptives. PGx testing helps identify the best contraceptive option for individuals by reducing side effects, improving efficacy, and minimising the time spent on finding a suitable method.

Are All PGx Tests Created Equal?

Published 24/10/2024

As pharmacogenomics (PGx) gains traction in personalised medicine, more healthcare providers are considering offering these tests to their patients. But with the growing number of PGx test providers, a critical question arises: Are all PGx tests created equal? Here’s what healthcare professionals should consider when selecting a PGx test provider.

How Pharmacogenomic Testing (PGx) Can Help in the Treatment of PMDD

Published 14/10/2024

Premenstrual Dysphoric Disorder (PMDD) is a severe form of premenstrual syndrome, popularly known as PMS. PMS is manageable and has mild symptoms, while PMDD is more severe, difficult to manage and characterised by intense emotional and physical symptoms.

Gene-Drug Interactions and Pharmacokinetics Explained

Published 10/10/2024

Pharmacogenomics (PGx) testing plays a pivotal role in this process, offering insights into gene-drug interactions that can optimise treatment strategies. A key component of this analysis is pharmacokinetics - the study of how drugs move through the body.

Understanding the Role of Pharmacogenetics in Modern Medicine

Published 04/10/2024

Pharmacogenetics or pharmacogenomics (PGx) is an exciting and growing field that explores the relationship between an individual’s genetic makeup and their response to medications. This personalised approach to treatment is paving the way for more personalised and effective medical care.

Which Antidepressants Are Least Associated with Weight Gain?

Published 01/10/2024

One of the most common concerns for individuals starting antidepressant therapy is the potential for weight gain. Searches like "which antidepressants cause the most weight gain" or "SSRI weight gain comparison" reveal just how prevalent this worry is.

Is ADHD Hereditary?

Published 30/09/2024

Although the exact causes of Attention deficit hyperactivity disorder (ADHD) are unknown, there are certain factors that play a role in an individual having it. These factors include genetics, pregnancy issues, neurobiological factors and environmental factors. A huge part of those factors is genetics.